Bryan Alexander Fisk MD
Critical Care Medicine
Medical Officer/TacMed/ASPR/HHS
Join to View Full Profile
600 N Union AvenueNew Braunfels, TX 78130
Phone+1 830-606-9111
Fax+1 210-703-0934
Dr. Fisk is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bryan Fisk is a critical care intensivist in New Braunfels, TX and is affiliated with multiple hospitals in the area, including CHRISTUS Santa Rosa Hospital - New Braunfels and CHRISTUS Santa Rosa Health System. He received his medical degree from McGovern Medical School at UTHealth and has been in practice 20 years. He has more than 20 publications and over 500 citings.
Education & Training
National Capital ConsortiumFellowship, Critical Care Medicine (Internal Medicine), 2004 - 2006- National Capital ConsortiumResidency, Internal Medicine, 1999 - 2002
McGovern Medical School at UTHealthClass of 1999
Certifications & Licensure
TX State Medical License 2011 - 2028
DC State Medical License 2023 - 2024
VA State Medical License 2001 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
Publications & Presentations
PubMed
- 1 citationsN-terminally LRMK-linked HER-2 peptides, AE-37 [p776(774-788)] and AE-47 [Ava-F7(776-788)], aid differentiation of E75-TCR+CD8+ cells to perforin-positive cells.Satoko Matsueda, Hui Gao, Clayton L. Efferson, Naotake Tsuda, Satoshi Ishiyama
Anticancer Research. 2009-07-01 - 2 citationsOutcomes following pneumococcal meningitis: room for improvement remains expansive.Bryan A. Fisk, William L. Jackson
Critical Care Medicine. 2006-11-01 - 24 citationsInduction of Tumor-Reactive CTL by C-Side Chain Variants of the CTL Epitope HER-2/neu Protooncogene (369-377) Selected by Molecular Modeling of the Peptide: HLA-A2 Com...Agapito Castilleja, Darrick Carter, Clay L. Efferson, Nancy E. Ward, Kouichiro Kawano
Journal of Immunology. 2002-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
